Spots Global Cancer Trial Database for Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)
Official Title: Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)
Study ID: NCT01103089
Conditions
Interventions
Study Description
Brief Summary: The purpose of the study is to determine patient characteristics from patients that have used Iressa for a period of minimal 3 years.
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, Amsterdam, , Netherlands
Research Site, Apeldoorn, , Netherlands
Research Site, Den Haag, , Netherlands
Research Site, Groningen, , Netherlands
Research Site, Helmond, , Netherlands
Research Site, Hengelo, , Netherlands
Research Site, Hoofddorp, , Netherlands
Research Site, Leiden, , Netherlands
Research Site, Veldhoven, , Netherlands
Research Site, Venlo, , Netherlands
Research Site, Zutphen, , Netherlands
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
